Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues

The Journal of Pathology

Volumn 162, Issue 4, 1990, Pages 279-284

  Wright, Nicholas A ^a   Poulsom, Richard ^a   Stamp, Gordon W H ^a   Hall, Peter A ^a   Jeffery, Rosemary E ^a   Longcroft, Janet M ^a   Rio, Marie‐Christine ^b   Tomasetto, Catherine ^b   Chambon, Pierre ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b CNRS   (France)

Author keywords

EGF URO; hSP; intestine; pS2; ulceration

Indexed keywords

EPIDERMAL GROWTH FACTOR; REGULATOR PROTEIN;

ARTICLE; CELL DAMAGE; DIGESTIVE SYSTEM ULCER; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REGULATOR GENE;

CELL LINE; CROHN DISEASE; EPIDERMAL GROWTH FACTOR; ESTROGENS; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; HUMAN; INTESTINAL MUCOSA; INTESTINE, SMALL; NEOPLASM PROTEINS; PANCREATIC DUCTS; PANCREATITIS; PEPTIC ULCER; PEPTIDE SYNTHESIS; PEPTIDES; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0025607961     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711620402     Document Type: Article

References (23)

1. Induction of a novel epidermal growth factor‐secreting cell lineage by mucosal ulceration in gastrointestinal stem cells
2. hSP, the domain‐duplicated homologue of pS2 protein, is coexpressed with pS2 in stomach but not breast carcinoma
3. Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands
4. Cloning of cDNA sequences of hormone‐regulated genes from the MCF‐7 human breast cancer cell line
5. Structure primaire de la protein humaine pS2
6. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, EGF, a tumour promoter (TPA), the c‐Ha‐ras oncoprotein and the c‐jun oncoprotein
7. Activation of pS2 gene transcription is a primary response to oestrogen in the human breast cancer cell line MCF‐7
8. Estrogen‐responsive element of the human pS2 gene is an imperfectly palindromic sequence
9. Prediction of relapse and survival in breast cancer patients
10. Breast cancer‐associated pS2 protein synthesis and secretion by normal stomach mucosa
11. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of oestrogen and progesterone receptors and the oncogene ERBB2
12. Oestrogen‐induced pS2 is similar to PSP and the Kringle domain
13. A new repetitive protein from Xenopus laevis is highly homologous to pancreatic spasmolytic polypeptide
14. A surprising sequence homology
15. Pancreatic spasmolytic polypeptide. I: Preparation and initial chemical characterisation of a new polypeptide from porcine pancreas
16. Pancreatic spasmolytic polypeptide III: pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid inhibitory effects
17. Receptor binding of pancreas in rat intestinal mucosal cell membranes inhibits adenylate cyclase activity
18. Pancreatic spasmolytic polypeptide II: radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice
19. Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes
20. Growth stimulatory effects of pancreatic spasmolytic polypeptide on cultured colon and breast tumour cells
21. A new family of growth factor‐like peptides